Osteoporosis in Men: An Endocrine Society Clinical Practice Guideline
Open accessThe DOI matches its Crossref record; 214 of the 216 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The aim was to formulate practice guidelines for management of osteoporosis in men. EVIDENCE: We used the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe the strength of recommendations and evidence quality. CONSENSUS PROCESS: Consensus was guided by systematic evidence reviews, one in-person meeting, and multiple conference calls and e-mails. Task Force drafts were reviewed successively by The Endocrine Society's Clinical Guidelines Subcommittee and Clinical Affairs Core Committee; representatives of ASBMR, ECTS, ESE, ISCD; and members at large. At each stage, the Task Force received written comments and incorporated needed changes. The reviewed document was approved by The Endocrine Society Council before submission for peer review. CONCLUSIONS: Osteoporosis in men causes significant morbidity and mortality. We recommend testing higher risk men [aged ≥70 and men aged 50-69 who have risk factors (e.g. low body weight, prior fracture as an adult, smoking, etc.)] using central dual-energy x-ray absorptiometry. Laboratory testing should be done to detect contributing causes. Adequate calcium and vitamin D and weight-bearing exercise should be encouraged; smoking and excessive alcohol should be avoided. Pharmacological treatment is recommended for men aged 50 or older who have had spine or hip fractures, those with T-scores of -2.5 or below, and men at high risk of fracture based on low bone mineral density and/or clinical risk factors. Treatment should be monitored with serial dual-energy x-ray absorptiometry testing.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Laboratory testing is indicated to exclude secondary causes of osteoporosis [1, 14, 17] (Table 4).”
From Clinician’s Guide to Prevention and Treatment of Osteoporosis (2014) · cites this paper as [17]
In the citing paper
“The Endocrine Society recommended that men with high fracture risk should receive an agent with proven antifracture activity irrespective of receiving testosterone or not (50).”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [50]
Citations
Cites
Holick, M. F., Binkley, N. C., Bischoff-Ferrari, H. A., Gordon, C. M., Hanley, D. A., Heaney, R. P., Murad, M. H., & Weaver, C. M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0385 · Cited by 10,538
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Osteoporosis Prevention, Diagnosis, and Therapy
NIH Consensus Development Panel on Osteoporosis Prevention, D. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.6.785 · Cited by 5,529
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures
Johnell, O., & Kanis, J. A. (2006) · Osteoporosis International · doi:10.1007/s00198-006-0172-4 · Cited by 4,704
Incidence and Economic Burden of Osteoporosis-Related Fractures in the United States, 2005–2025
Burge, R., Dawson-Hughes, B., Solomon, D. H., Wong, J. B., King, A., & Tosteson, A. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.061113 · Cited by 4,026
Ross, A. C., Manson, J. E., Abrams, S. A., Aloia, J. F., Brannon, P. M., Clinton, S. K., Durazo-Arvizu, R. A., Gallagher, J. C., Gallo, R. L., Jones, G., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2704 · Cited by 4,026
Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07088-2 · Cited by 3,846
Epidemiology of adult fractures: A review
Court-Brown, C. M., & Caesar, B. (2006) · Injury · doi:10.1016/j.injury.2006.04.130 · Cited by 3,672
Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis
Black, D. M., Delmas, P. D., Eastell, R., Reid, I. R., Boonen, S., Cauley, J. A., Cosman, F., Lakatos, P., Leung, P. C., Man, Z., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067312 · Cited by 2,986
Self-citationVitamin D deficiency: a worldwide problem with health consequences
Holick, M. F., & Chen, T. C. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.4.1080s · Cited by 2,689 · cited 2×
“Vitamin D at high doses may result in toxicity (hypercalcemia or hypercalciuria), but this is rarely seen unless 25(OH)D levels exceed 150 ng/ml (375 nmol/liter) (121), and such levels are unlikely with the doses of vitamin D recommended here.”
Background
Research works printed but not linked: 4
- Rao, 1996, Metabolic bone disease in gastrointestinal, hepatobiliary, and pancreatic disorders, 306
- Siegel, 1995, Metabolic bone diseases and disorders of the gastrointestinal tract, 113
- Barragry, 1978, Intestinal cholecalciferol absorption in the elderly and in young subjects., Clin Sci Mol Med, 55, 213
- Finkelstein, 2008, Toward a physiologically-based definition of hypogonadism in men: dose-response relationship between testosterone and bone resorption (Abstract 1102). ASBMR 30th Annual Meeting 1001–1300., J Bone Miner Res, 23, S2
Cited by
Items 401–500 of 669
Revisão sobre fraturas osteoporóticas: Ocorrência, prevenção e consequências
Elias, N., Ribeiro, J. E. G., Campinho, L. A., Reis, C., Elias, L. A. M. S., & Labronici, P. J. (2025) · Revista Brasileira de Ortopedia · doi:10.1055/s-0045-1809515 · Cited by 3
Screening for multiple myeloma has low yield as part of a secondary osteoporosis screen
Gong, J. Y., Iuliano, S., Tint, A. N., Seah, J.-M., Nguyen, M., & Chiang, C. Y. (2025) · Pathology · doi:10.1016/j.pathol.2025.11.004 · Cited by 3
Wass, J. A. H., Owen, K. R., & Turner, H. E. (2014) · Oxford University Press eBooks · doi:10.1093/med/9780199644438.003.0006 · Cited by 3
Liu, X., Choudhury, A., & Anderson, C. (2019) · PubMed Central · Cited by 3
Yuan, W., Xu, J., Yang, N., Wang, H., Li, J., Zhang, M., & Zhu, M. (2023) · Gels · doi:10.3390/gels10010031 · Cited by 3
Valderrábano, R. J., Pencina, K. M., Shang, Y. V., Cruz, E. C. E., Dixon, R., Ghattas, C., Wilson, L. A., Reid, K. F., Storer, T. W., Garrahan, M., et al. (2024) · Bone · doi:10.1016/j.bone.2024.117039 · Cited by 3
Geschlechterperspektiven in der medizinischen Forschung und Versorgung
Oertelt‐Prigione, S. (2024) · Edition Fachdidaktiken · doi:10.1007/978-3-658-43616-2_5 · Cited by 3
Effect of cigarette smoking on bone mineral density and mass of bone tissue in males
Kopiczko, A., & Cieplińska, J. (2014) · Medycyna Ogólna i Nauki o Zdrowiu · doi:10.5604/20834543.1132054 · Cited by 3
Vázquez, F. L., Hernández, S. H., Triguero, C. C., Prado, M., & Ballesteros, L. C. (2014) · Reumatología Clínica · doi:10.1016/j.reuma.2014.05.003 · Cited by 3
Chahin, R., Gulamhusein, H., Breunis, H., & Alibhai, S. M. H. (2016) · Supportive Care in Cancer · doi:10.1007/s00520-016-3320-1 · Cited by 3
The Current Issues on Osteoporosis among Male Saudi Arabians
Sadat‐Ali, M., Almomen, A. W., AlOmar, H. K., AlAlwan, S. A., Gullenpet, A. H., & AlAnii, F. M. (2017) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 3
Osteoporosis and Fragility Fracture
Lim, J., Beom, J., & Lee, S. Y. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-54454-2.00003-0 · Cited by 3
Povoroznyuk, V. V., & Puzanovа, О. G. (2019) · PAIN JOINTS SPINE · doi:10.22141/2224-1507.9.4.2019.191922 · Cited by 3
Adler, R. A. (2020) · Contemporary Endocrinology · doi:10.1007/978-3-319-69287-6_20 · Cited by 3
Self-citationKao, F., Hsu, Y., Chen, T., Tu, Y., & Liu, P. (2022) · Medicine · doi:10.1097/md.0000000000031604 · Cited by 3
Cancado, B. L., Miranda, L. C. M., Madeira, M., & Farias, M. L. F. (2015) · Revista do Colégio Brasileiro de Cirurgiões · doi:10.1590/0100-69912015001012 · Cited by 3
LaFleur, J., Steenhoek, C. L., Horne, J., Meier, J. L., Nebeker, J. R., Mambourg, S., Swislocki, A., & Carmichael, J. M. (2015) · Annals of Pharmacotherapy · doi:10.1177/1060028015572819 · Cited by 3
Caveats in diagnosis of osteoporosis
Acharya, S., Adsul, N. M., Palukuri, N., & Acharya, A. S. (2017) · Indian Journal of Medical Specialities · doi:10.1016/j.injms.2017.05.004 · Cited by 3
Valencia, W. M., & Florez, H. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-31831-8_22 · Cited by 3
ORWOLL, E. S. (2013) · Wiley eBooks · doi:10.1002/9781118453926.ch62 · Cited by 3
Self-citationPrimary Care of Transgender Adults
Radix, A. (2019) · Contemporary Endocrinology · doi:10.1007/978-3-030-05683-4_4 · Cited by 3
Chronic Disease Screening and Health Promotion Strategies for Older Men
Kriebel-Gasparro, A. M., Gupta, A., & Chappell, L. (2022) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2022.11.002 · Cited by 3
Postmenopausal osteoporosis: standard diagnostic and therapeutic practice
Payer, J., Killinger, Z., Jackuliak, P., & Kužma, M. (2018) · Clinical Osteology · doi:10.36290/clo.2018.005 · Cited by 3
The Potential of Egg White Ovotransferrin as a Functional Food Ingredient against Osteoporosis
Shang, N. (2019) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-5njv-av60 · Cited by 3
Bhasin, S., & Snyder, P. J. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab246 · Cited by 3
Hamilton, B., Staines, K. A., Kelley, G. A., Kelley, K. S., Kohrt, W. M., Pitsiladis, Y. P., & Guppy, F. M. (2021) · SportRxiv (OSF Preprints) · doi:10.31236/osf.io/63a7g · Cited by 3
Role of Estrogens and Androgens in Osteoporosis
Laurent, M. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65814-2 · Cited by 3
Integrating Sex and Gender in Medical Research: SAGER Guidelines
Karaman, İ. G. Y. (2025) · Nöro Psikiyatri Arşivi · doi:10.29399/npa.29184 · Cited by 3
Launching the Emirates Osteoporosis Society (EOS) Guidelines 2022 in the United Arab Emirates
Izzi, M. A., Suhaili, A. A., El-Serafi, A. T., Abogamal, A. F., Tapponi, L., & Brodzinski, Z. (2023) · New Emirates Medical Journal · doi:10.2174/04666230126094059 · Cited by 2
Jiménez-Ortega, R. F., Cantellano-Sánchez, P. M., Ortega-Meléndez, A. I., & Velázquez‐Cruz, R. (2023) · Revista de Osteoporosis y Metabolismo Mineral · doi:10.20960/revosteoporosmetabminer.00024 · Cited by 2
Özcan, B., Ceylan, S., Özcan, M., Güner, M., Balcı, C., Cankurtaran, M., Halil, M. G., & Doğu, B. B. (2025) · British Journal of Clinical Pharmacology · doi:10.1002/bcp.70243 · Cited by 2
Vincentis, S. D., Russo, A., Taliani, E., Ansaloni, A., Domenici, D., D’Angelo, G., Demichelis, V. M., Madeo, B., & Rochira, V. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02753-8 · Cited by 2
Knowledge, attitude, and practice of osteoporosis and hip fracture in older Chinese adults
Ma, F., Wang, Z., Luo, X., Wu, N., Ma, X., Hu, Y., & Yu, B. (2026) · Scientific Reports · doi:10.1038/s41598-026-35046-y · Cited by 2
Cevallos, A., Tarragó, A., & Rissech, C. (2026) · American Journal of Biological Anthropology · doi:10.1002/ajpa.70241 · Cited by 2
Testosterone and Bone Health in Men
Kafel, H., & Basaria, S. S. (2026) · Current Osteoporosis Reports · doi:10.1007/s11914-026-00971-4 · Cited by 2
McHan, L., & Augustine, M. (2024) · JCEM Case Reports · doi:10.1210/jcemcr/luae073 · Cited by 2
ZOLEDRONIC ACID IN THE TREATMENT OF OSTEOPOROSIS AND OTHER SKELETAL DISORDERS
Vorotnikova, S. Y., & Pigarova, E. A. (2016) · Osteoporosis and Bone Diseases · doi:10.14341/osteo2016323-27 · Cited by 2
Principles of Diagnosis and Treatment of Osteoporosis
Caraccio, D. M., & Jones, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-42894-5_7 · Cited by 2
Baxter, S., Farris, E., Johnson, A. H., Brennan, J. C., Friedmann, E., Turcotte, J. J., & Keblish, D. (2023) · Cureus · doi:10.7759/cureus.40355 · Cited by 2
DXA bone mineral density in males: retrospective study in real life
Viapiana, O., Idolazzi, L., Orsolini, G., Adami, S., Rossini, M., & Gatti, D. (2014) · Aging Clinical and Experimental Research · doi:10.1007/s40520-014-0292-1 · Cited by 2
Evidence-based Screening for Low Bone Mineral Density in HIV-infected Men
Albright, P., Du, P., Haas, R. E., & Pugh, L. C. (2014) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/j.jana.2014.03.006 · Cited by 2
for the Hellenic ExFOS study group, Aloumanis, K., Kapetanos, G. A., Bartzis, N., & Drossinos, V. (2015) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-015-0600-8 · Cited by 2
Bone Health in Prostate Cancer
Pietzak, E. J., & Mucksavage, P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800077-9.00053-0 · Cited by 2
Testosterone and Male Osteoporosis
Shin, D.-E., Ahn, T., Kim, J.-W., Oh, C.-H., & Choi, S. (2018) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-018-9245-0 · Cited by 2
Postmenopausal Osteoporosis Treatment Update
Wong, E. K. C., & Παπαϊωάννου, Α. (2018) · Current Treatment Options in Rheumatology · doi:10.1007/s40674-018-0098-y · Cited by 2
Остеопороз при злоякісних новоутвореннях
Povoroznyuk, V. V., Bystrytska, M. А., & Musiіenko, А. S. (2018) · PAIN JOINTS SPINE · doi:10.22141/2224-1507.8.2.2018.137192 · Cited by 2
Management of Male Osteoporosis
Geusens, P., & van den Bergh, J. P. (2018) · Springer eBooks · doi:10.1007/978-3-319-26757-9_7 · Cited by 2
Practice Patterns in the Treatment of Male Osteoporosis
Papaleontiou, M., Choksi, P. U., & Reyes‐Gastelum, D. (2019) · Endocrine Practice · doi:10.4158/1934-2403-25.10.1077 · Cited by 2
ГЕНЕТИЧЕСКИЕ ОСНОВЫ ОСТЕОПОРОЗА
Mirgalieva, R. Y., Хуснутдинова, Э. К., & Khusainova, R. I. (2018) · Nauchno-prakticheskii zhurnal «Medicinskaia genetika» · doi:10.25557/2073-7998.2018.07.3-10 · Cited by 2
Challenges in Screening and Diagnosis of Osteoporosis
Cusano, N. E. (2021) · Springer eBooks · doi:10.1007/978-3-030-83951-2_1 · Cited by 2
ORWOLL, E. S., & Adler, R. A. (2018) · Wiley eBooks · doi:10.1002/9781119266594.ch56 · Cited by 2
Self-citationKallmann Syndrome : Clinical and molecular genetic features in Finland
Laitinen, E. (2012) · Helda - University of Helsinki Institutional Repository · Cited by 2
Anagnostis, P. G., Karras, S. Ν., & Goulis, D. G. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.895312 · Cited by 2
de Médecine, F. (2012) · Cited by 2
Schousboe, J. T. (2016) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2016.06.005 · Cited by 2
For the Osteoporotic Fractures in Men (MrOS) Study Group, Fink, H. A., Litwack‐Harrison, S., Taylor, B. C., Bauer, D. C., ORWOLL, E. S., Lee, C. G., Barrett-Connor, E. L., Schousboe, J. T., Kado, D. M., et al. (2016) · Osteoporosis International · doi:10.1007/s00198-016-3805-2 · Cited by 2
Self-citationBarrera, F. J., Raygoza-Cortez, K., García-Leal, M., Brito, J. P., Ospina, N. S., & Rodríguez‐Gutiérrez, R. (2021) · Endocrine · doi:10.1007/s12020-020-02592-y · Cited by 1
Male hypogonadism with its systemic complications
Niedobylski, S., Laszczak, K., Warchoł, K., Marczak, A., Dobosz, M., Lewicki, M., & Obel, E. (2020) · Journal of Education Health and Sport · doi:10.12775/jehs.2020.10.09.020 · Cited by 1
Gennari, L., Bandeira, L., Costa, A. G., Cusano, N. E., Silva, B. C. C., & Bilezikian, J. P. (2022) · Springer eBooks · doi:10.1007/978-3-030-90684-9_25 · Cited by 1
Self-citationGrygorieva, N. V., Bystrytska, M. А., & Поворознюк, В. В. (2022) · PAIN JOINTS SPINE · doi:10.22141/pjs.12.4.2022.344 · Cited by 1
Tibbetts, K. Q., Mhaskar, R. S., & Prakash, N. S. (2025) · Cureus · doi:10.7759/cureus.80490 · Cited by 1
Shah, N., Galitzer, H., Yalamanchi, S., & Sellmeyer, D. E. (2025) · JBMR Plus · doi:10.1093/jbmrpl/ziaf089 · Cited by 1
The Incidence of Premature Bone Demineralization in Breast Cancer Patients Under 65
Tibbetts, K. Q., Huang, K. A., Goltz, D., Levin, M., & Prakash, N. S. (2025) · Clinical Breast Cancer · doi:10.1016/j.clbc.2025.08.006 · Cited by 1
Hip Fractures and Hypogonadism in Young Males: A Missed Opportunity for Secondary Prevention?
Khin, C., Kyaw, O., Thangaraj, S., Akinsolu, O., Elfiky, A., D’sa, P., Chan, G., & Rogers, B. A. (2025) · Cureus · doi:10.7759/cureus.90445 · Cited by 1
Yoshimura, F. B., Pontes, Í. C. D. M., Fukamizu, E. M. N., Fonseca, E. K. U. N., Yokoo, P., Osawa, A., & Castro, A. D. A. E. (2025) · Radiologia Brasileira · doi:10.1590/0100-3984.2025.0073 · Cited by 1
Stem Cells and their Key Derivatives in Degenerative Musculoskeletal Diseases
Khan, N., Ahmadova, Z., Zeng, B., Ahmed, W., Shafiq, T., Zhang, Z., Su, A., Muhammad, N., Khan, S., Liang, Y., et al. (2026) · Stem Cell Reviews and Reports · doi:10.1007/s12015-026-11080-1 · Cited by 1
Testosterone replacement therapy in older men: skeletal outcomes and fracture risk
Szarpak, L., Al-Jeabory, M., Pecold, J., & Maslyk, M. M. (2026) · The Aging Male · doi:10.1080/13685538.2026.2655544 · Cited by 1
Rouach, V., Versano, Z., Sasson, M., Greenman, Y., Makori, A., Chodick, G., & Goldshtein, I. (2026) · Archives of Osteoporosis · doi:10.1007/s11657-026-01701-0 · Cited by 1
Scala, A., Delbarba, A., Ceolin, C., Camozzi, V., Giannini, S., Procacci, S., Silvestrini, I., Ferlin, A., Sergi, G., Cappelli, C., et al. (2026) · Osteoporosis International · doi:10.1007/s00198-026-07995-7 · Cited by 1
Wan, Y., Sheng, X., Kan, W., Ji, J., Hu, H., Hu, J., & Lu, W. (2026) · Orthopedic Reviews · doi:10.52965/001c.161323 · Cited by 1
Comparing Motivations for Anabolic-Androgenic Steroid Use Among an International Sample of Men
Ahmadinejad, B., Bonenti, B., Puljević, C., Ferris, J., WINSTOCK, A. R., Khan, I., Ball, L., FISHER, K., & Piatkowski, T. M. (2026) · Substance Use & Misuse · doi:10.1080/10826084.2026.2675989 · Cited by 1
Silverstein, W. K., Mayrer, B. M., Stall, N. M., Zipursky, J. S., & Anderson, T. S. (2026) · Journal of General Internal Medicine · doi:10.1007/s11606-026-10659-1 · Cited by 1
Silva, I. C. J., Albergaria, B., Teixeira, B. C., & Lazaretti-Castro, M. (2026) · Archives of Osteoporosis · doi:10.1007/s11657-026-01734-5 · Cited by 1
Osteoporosis: ¿a quién tratar?, ¿con qué? y ¿por cuánto tiempo?
Reyes, C., & Prieto‐Alhambra, D. (2015) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/j.fmc.2015.03.006 · Cited by 1
Costa, A. G., Cusano, N. E., Silva, B. C. C., & Bilezikian, J. P. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8684-8_25 · Cited by 1
Self-citationDietary Supplements in Older Adults
Dwyer, J. T., Costello, R. B., Merkel, J. M., & Coates, P. M. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1929-1_23 · Cited by 1
Prescription of Alendronate and Risedronate in Men: Off-label Use in a Health Area
Vázquez, F. L., Hernández, S. H., Triguero, C. C., Prado, M., & Ballesteros, L. C. (2014) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2014.05.004 · Cited by 1
Vertebral osteoporotic fractures with height loss secondary to Cushing's disease.
Nogueira, C., Souto, S. B., Rios, E., Pereira, J., Vinha, E., Freitas, P., & Carvalho, D. M. (2015) · PubMed · Cited by 1
Osteoporosis in cystic fibrosis patients: prevention and therapeutic opportunities
Baranova, I. A., Kondrat'eva, E. I., & Krasovskiy, S. (2017) · PULMONOLOGIYA · doi:10.18093/0869-0189-2017-27-4-537-545 · Cited by 1
Management of Male Osteoporosis: an Update
Almohaya, M. S., Alobedollah, A., & Kendler, D. L. (2018) · Current Treatment Options in Rheumatology · doi:10.1007/s40674-018-0107-1 · Cited by 1
Al-Lami, R. A., Graham, J. E., Deer, R., Westra, J. R., Williams, S. B., Kuo, Y., & Baillargeon, J. (2019) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000001127 · Cited by 1
Частота і структура основних чинників ризику у жінок із постменопаузним остеопорозом
Pankiv, І. V. (2021) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.14.8.2018.154854 · Cited by 1
Osteoporosis Screening and Diagnosis
Yu, E. W.-Y. (2020) · Contemporary Endocrinology · doi:10.1007/978-3-319-69287-6_7 · Cited by 1
Current Approaches to the Basic Aspects of Osteoporosis
Ersoy, C. (2020) · Turkish Journal of Internal Medicine · doi:10.46310/tjim.732932 · Cited by 1
Introduction: Gender Differences in Osteoporosis: From Research to Treatment
Foresta, C. (2020) · Trends in andrology and sexual medicine · doi:10.1007/978-3-319-96376-1_1 · Cited by 1
Mettawi, A. S., Soliman, S., & Taha, M. E. (2020) · Archives of Osteoporosis · doi:10.1007/s11657-020-00830-4 · Cited by 1
Zhao, J., Liu, L., Lv, S., Wang, C., Yue, H., & Zhang, Z. (2021) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s344818 · Cited by 1
Cirnigliaro, C. M., Myslinski, M. J., Parrott, J. S., Cross, G. T., Gilhooley, S. K., Fountaine, M. F. L., Kirshblum, S., McClure, I. A., Forrest, G. F., Spungen, A. M., et al. (2022) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2022.01.005 · Cited by 1
Pacharne, S., Livesey, M. R., Kadmiel, M., Wang, N., Caron, K. M., Richards, G. O., & Skerry, T. M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.807882 · Cited by 1
Shen, X., Tan, S., Feng, X., Fu, W., Hu, Y.-Q., Li, M., Wang, W., Yuan, H., Liu, L., Wang, C., et al. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/2461716 · Cited by 1
Sulaiman, S. R., Alturk, Y. M., AlArabi, R., Alsisi, E. M., Rajeh, A. A., & Sulaimani, A. B. (2022) · Journal of Musculoskeletal Surgery and Research · doi:10.25259/jmsr_1_2022 · Cited by 1
Khram, N., Aboul-Ela, M., Hijazi, M. A., & Soubra, L. (2022) · BAU Journal - Health and Wellbeing · doi:10.54729/tjqn9288 · Cited by 1
Pereira, L. C. D. L., da Silveira, J. H. C., & Guerra, I. D. O. F. (2022) · International Journal of Health Management Review · doi:10.37497/ijhmreview.v8i1.316 · Cited by 1
Oğuz, S. H., & Yıldız, B. O. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-98804-9.00029-3 · Cited by 1
Clinical Manifestation and Diagnosis of Androgen Deficiency
Święcicka, A., & Wu, F. C. W. (2017) · Endocrinology · doi:10.1007/978-3-319-44441-3_23 · Cited by 1
Jeeyavudeen, M. S., Hansdak, S. G., Thomas, N., Thangakunam, B., Gowri, M. S., & Paul, T. V. (2023) · Aging Medicine · doi:10.1002/agm2.12239 · Cited by 1
Part II : Interactive case: Drug‐induced endocrine disorders
Donihi, A. C. (2023) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1813 · Cited by 1
First Ecuadorian statement consensus for the evaluation and treatment of osteoporosis
Ríos, C., Maldonado, G., Vargas, S., González, J., Vera, C., Zuñiga, A., Martínez, J., Castillo, M. R. R., Jervis, R., Ventura, R., et al. (2023) · Archives of Osteoporosis · doi:10.1007/s11657-023-01263-5 · Cited by 1
A cross-sectional study on Chinese oncology nurses’ knowledge of bone health among cancer patients
Shan, J., Lv, S., Chen, L., Li, T., Li, J., Wang, S., & Zhang, C. (2023) · Supportive Care in Cancer · doi:10.1007/s00520-023-07966-2 · Cited by 1
Cosme, I., Nobre, E. L., Travessa, A., dos Santos, C. R., Rocha, J., Lopéz‐Presa, D., & Barbosa, A. P. (2023) · Cureus · doi:10.7759/cureus.47461 · Cited by 1
Metadata
- Authors
- Watts, N. B., Adler, R. A., Bilezikian, J. P., Drake, M. T., Eastell, R., Orwoll, E. S., & Finkelstein, J. S.
- Affiliations
- Mercy Health (US)
- Virginia Commonwealth University (US)
- Columbia University (US)
- Mayo Clinic (US)
- University of Sheffield (GB)
- Oregon Health & Science University (US)
- Harvard University (US)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2012-06-01
- Volume
- 97
- Issue
- 6
- Pages
- 1802-1822
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2075195284
- Cited by
- 611
- References
- 216
- Citations by year
- 2026: 38 · 2025: 42 · 2024: 32 · 2023: 46 · 2022: 53 · 2021: 41 · 2020: 49 · 2019: 36 · 2018: 48 · 2017: 39 · 2016: 42 · 2015: 31 · 2014: 50 · 2013: 51 · 2012: 11
- FWCI
- 48.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Keywords
- male osteoporosis, osteoporosis management, fracture risk assessment, dual-energy X-ray absorptiometry, bone mineral density, calcium and vitamin D supplementation, weight-bearing exercise, smoking, alcohol consumption, T-score, osteopenia, older men
- MeSH terms
- Aged, Endocrinology, Humans, Male, Middle Aged, Osteoporosis, Risk Factors, Evidence-Based Medicine, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.